CAPTRUST Financial Advisors
VIR icon

CAPTRUST Financial Advisors’s Vir Biotechnology VIR Stock Holding History

CAPTRUST Financial Advisors’s Portfolio VIR Stock Details VIR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$336K Buy
37,555
+17,781
+90% +$142K ﹤0.01% 2312
2025
Q4 		$119K Buy
19,774
+672
+4% +$4K ﹤0.01% 2593
2025
Q3 		$109K Sell
19,102
-11,637
-38% -$59.5K ﹤0.01% 2500
2025
Q2 		$155K Buy
30,739
+8,739
+40% +$46.9K ﹤0.01% 2341
2025
Q1 		$143K Buy
22,000
+1,497
+7% +$13.3K ﹤0.01% 2208
2024
Q4 		$150K Buy
20,503
+4,683
+30% +$36.9K ﹤0.01% 2174
2024
Q3 		$118K Buy
+15,820
New +$137K ﹤0.01% 2193
2022
Q3 		– Sell
-1,823
Closed -$46K – 4005
2022
Q2 		$46K Buy
1,823
+1,690
+1,271% +$39.5K ﹤0.01% 2821
2022
Q1 		$3K Sell
133
-3
-2% -$89 ﹤0.01% 4395
2021
Q4 		$6K Buy
+136
New +$5.33K ﹤0.01% 4008
2021
Q1 		– Sell
-500
Closed -$13K – 4479
2020
Q4 		$13K Buy
+500
New +$16.3K ﹤0.01% 2464

Other funds holding VIR

BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
AVM
Arch Venture Management Chicago, Illinois $677M AUM 322.07% 1-Year Est. Return
SIAU
SB Investment Advisers (UK) London, United Kingdom $7.73B AUM 2.35% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
GP
GSK plc London $599M AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Goldman Sachs
Goldman Sachs New York $761B AUM 31.28% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $1.66B AUM 340.85% 1-Year Est. Return